Tag: cardiac marker market share

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Cardiac Marker Market Grown from 2024 to 2025?

In recent times, the cardiac marker market has seen speedy progression in its size. It is projected to surge from $11.26 billion in 2024 to $12.47 billion in 2025, registering a compound annual growth rate (CAGR) of 10.8%. The expansion observed in the historic period can be linked to an escalating prevalence of cardiovascular disorders, senior citizen population and cardiovascular risk factors, awareness drives and health checkups, incorporation of biomarkers into clinical application, along with stiff regulatory norms and guidelines.

What Growth Rate Is Anticipated for the Cardiac Marker Market in the Coming Years?

Over the coming years, substantial expansion is expected in the cardiac marker market size, with projections suggesting it will reach $20.35 billion by 2029, reflecting a compound annual growth rate (CAGR) of 13.0%. Factors contributing to this projected growth during the forecast period include the increasing prevalence of lifestyle-related diseases, advancements in remote monitoring and telemedicine, individualized medicine and precision diagnostics, as well as the adoption of point-of-care testing (POCT). The healthcare industry’s collaborations and partnerships are also seen as driving forces. Predicted trends for the forecast period include the discovery and validation of biomarkers, personalized medicine strategies, advances in assay platform technology, the incorporation of high-sensitivity troponin tests, and a surge in the incidence of cardiovascular diseases.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10053&type=smp

Who Are the Leading Companies in the Cardiac Marker Market?

Major companies operating in the cardiac marker market include Abbott Laboratories Inc., Siemens AG, Danaher Corporation, BioMérieux SA, F. Hoffmann-La Roche AG, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Guangzhou Wondifo Biotech Co. Ltd., Creative Diagnostics, PerkinElmer Inc., Tosoh Corporation, Quidel Corporation, Randox Laboratories Ltd., Getinge Group, LSI Medience Corporation, Ortho Clinical Diagnostics, DiaSorin, 3M Company, Atom Medical Corporation, Bionet America Inc., Bistos Inc., CareFusion Corporation, Clinical Innovations LLC, Abcam plc, General Electric Company

What Are the Key Drivers of the Cardiac Marker Market?

The escalation in heart-related ailments is projected to drive the expansion of the cardiac marker industry. Cardiac illnesses represent a variety of disorders that impact the heart’s structure or function and give rise to multiple medical complications. Cardiac markers serve as a diagnostic tool and a monitoring system for several heart conditions like heart attacks, angina, heart failure, and other cardiovascular diseases. Consequently, there has been an upsurge in the demand for these diagnostic tests or cardiac markers. For example, as per the British Heart Foundation, a cardiovascular research charity based in the UK, England witnessed an increase of 30,000 deaths due to coronary heart disease from the onset of the pandemic till August 2022. An astounding 346,000 individuals were recorded on the cardiac waiting list by August 2022. Thus, the growing incidence of heart diseases is anticipated to spur the growth of the cardiac marker market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=10053&type=smp

What Are the Key Market Segments in the Cardiac Marker Industry?

The cardiac marker market covered in this report is segmented –

1) By Biomarker: Troponin, Creatine Kinase-MB (CK-MB), B-type Natriuretic Peptide (BNP), Myoglobin, Other Biomarkers

2) By Product: Reagent, Instrument, Chemiluminescence, Immunofluorescence, Immunochromatography, ELISA

3) By Indication: Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Other Indications

4) By End User: Laboratory Testing Facilities, Hospital Labs, Reference Labs, Contract Testing Labs, Point-Of-Care Testing Facilities, Academic Institutions

Subsegments:

1) By Troponin: Troponin I, Troponin T, Troponin Diagnostic Kits

2) By Creatine Kinase-MB (CK-MB): CK-MB Test Kits, CK-MB Diagnostic Panels

3) By B-Type Natriuretic Peptide (BNP): BNP Test Kits, NT-ProBNP Test Kits, BNP Diagnostic Panels

4) By Myoglobin: Myoglobin Test Kits, Myoglobin Diagnostic Panels

5) By Other Biomarkers: Ischemia Modified Albumin (IMA), Heart Fatty Acid Binding Protein (HFABP), C-Reactive Protein (CRP)

What Are the Latest Trends in the Cardiac Marker Market?

The cardiac marker industry is currently experiencing a surge in product innovation trends driven by major market participants’ desire to solidify their standing through unique solutions. As an example, MiRxes, a biotech firm from Singapore, corroborated a microRNA-based diagnostic check for early illness identification in September 2022. Once this test is made commercially available, it will augment MiRxes’ existing assortment of cancer blood tests, thereby providing an extensive array of preliminary detection techniques. This development will help mitigate the escalating clinical and socioeconomic impacts of fatal diseases such as cancer and cardio-pulmonary disorders.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/cardiac-marker-global-market-report

What Are the Key Regional Markets in the Cardiac Marker Industry?

North America was the largest region in the cardiac marker market in 2024. The regions covered in the cardiac marker market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10053

This Report Delivers Insight On:

1. How big is the cardiac marker market, and how is it changing globally?

2. Who are the major companies in the cardiac marker market, and how are they performing?

3. What are the key opportunities and risks in the cardiac marker market right now?

4. Which products or customer segments are growing the most in the cardiac marker market?

5. What factors are helping or slowing down the growth of the cardiac marker market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the cardiac marker industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Is the Current and Projected Market Size of the Cardiac Marker Market Through 2034?

The market size for cardiac markers has seen a fast-paced expansion in the recent past. The projections for the growth of this market show an increase from $11.26 billion in 2024 to $12.47 billion in 2025, with a compound annual growth rate (CAGR) of 10.8%. Key contributing factors to this historic growth include a rise in cardiovascular disease cases, an aging population and associated cardiovascular risks, heightened awareness through health education and screenings, the use of biomarkers in clinical protocols, and rigorous regulations and guidelines.

In the coming years, the cardiac marker market is projected to experience significant expansion, with a forecasted valuation of “$20.35 billion by the year 2029, and an estimated compound annual growth rate (CAGR) of 13.0%. The surge in this forecast period is driven by increasing instances of lifestyle-related ailments, the proliferation of remote monitoring and telemedicine, advancements in personalized medicine and precision diagnostics, adoption of point-of-care testing (poct), and collaborations and partnerships within the healthcare sector. Over the forecast period, major trends expected to surface include the discovery and validation of biomarkers, the use of personalized medicine strategies, advancements in assay platform technologies, incorporating high-sensitive troponin tests, and an increase in the prevalence of cardiovascular diseases.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10053&type=smp

What are the Fundamental Drivers and Innovations Shaping the Cardiac Marker Market?

The cardiac marker market is predicted to expand due to the increasing incidence of heart-related diseases. These diseases, which can harm the heart’s structure or function and lead to various health issues, are becoming more and more common, necessitating the use of cardiac markers. These markers are essential for diagnosing and monitoring a variety of heart conditions, such as heart attacks, angina, heart failure, and other cardiovascular diseases. Consequently, the demand for these diagnostic tests or cardiac markers is on the rise. For example, the British Heart Foundation reported an additional 30,000 deaths from coronary heart disease in England from the start of the pandemic until August 2022. Furthermore, by the end of August 2022, a staggering 346,000 individuals were waiting for cardiac treatments. This mounting prevalence of heart diseases undeniably stimulates the growth of the cardiac marker market.

How Is the Cardiac Marker Market Segmented?

The cardiac marker market covered in this report is segmented –

1) By Biomarker: Troponin, Creatine Kinase-MB (CK-MB), B-type Natriuretic Peptide (BNP), Myoglobin, Other Biomarkers

2) By Product: Reagent, Instrument, Chemiluminescence, Immunofluorescence, Immunochromatography, ELISA

3) By Indication: Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Other Indications

4) By End User: Laboratory Testing Facilities, Hospital Labs, Reference Labs, Contract Testing Labs, Point-Of-Care Testing Facilities, Academic Institutions

Subsegments:

1) By Troponin: Troponin I, Troponin T, Troponin Diagnostic Kits

2) By Creatine Kinase-MB (CK-MB): CK-MB Test Kits, CK-MB Diagnostic Panels

3) By B-Type Natriuretic Peptide (BNP): BNP Test Kits, NT-ProBNP Test Kits, BNP Diagnostic Panels

4) By Myoglobin: Myoglobin Test Kits, Myoglobin Diagnostic Panels

5) By Other Biomarkers: Ischemia Modified Albumin (IMA), Heart Fatty Acid Binding Protein (HFABP), C-Reactive Protein (CRP)

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=10053&type=smp

Which Regions Are Driving the Next Phase of the Cardiac Marker Market Growth?

North America was the largest region in the cardiac marker market in 2024. The regions covered in the cardiac marker market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Key Trends Are Shaping the Future of the Cardiac Marker Market?

The cardiac marker market is currently experiencing a surge in product innovation, a trend which is becoming increasingly popular. Many key market players are honing in on introducing innovative solutions to solidify their market standing. As an example, MiRxes, a biotechnology firm based in Singapore, has in September 2022, successfully validated a diagnostic test based on microRNA for early detection and diagnosis of the disease. Upon commercialization, this test would bolster the company’s existing line of blood tests for cancer, providing comprehensive early detection solutions, meant to mitigate the mounting clinical and socioeconomic impact of serious diseases, including cancer and cardio-pulmonary conditions.

View the full report here:

https://www.thebusinessresearchcompany.com/report/cardiac-marker-global-market-report

How Is the Cardiac Marker Market Defined and What Are Its Core Parameters?

Cardiac markers are biomolecules that are released into the bloodstream when there is damage or stress to the heart muscle. It is used to diagnose and monitor a variety of cardiac diseases, including heart attacks, angina, and heart failure.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10053

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

How Are Key Drivers Contributing to the Growth and Expansion of the Cardiac Marker Market?

The cardiac marker market is projected to grow due to the increasing occurrence of heart-related diseases. Conditions that affect the heart’s structure or function, resulting in various health issues, are categorized as cardiac diseases. Diagnostic tests or cardiac markers are utilized to detect and monitor numerous heart ailments like heart attacks, heart failure, angina, and other cardiovascular diseases. Consequently, the need for these cardiac markers has escalated. For example, the British Heart Foundation, a cardiovascular research organization in the UK, stated that from the start of the pandemic until August 2022, England witnessed 30,000 additional deaths from coronary heart disease. Furthermore, by the end of August 2022, a staggering 346,000 individuals were on the cardiac waiting list. Thus, the growing prevalence of heart diseases is set to stimulate the expansion of the cardiac marker market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10053&type=smp

#What Growth Opportunities Will Drive the Cardiac Marker Market’s CAGR Through 2034?

The size of the cardiac marker market has seen substantial expansion in the past few years. It is forecasted to expand from $11.26 billion in 2024 to $12.47 billion in 2025, with a compound annual growth rate (CAGR) of 10.8%. This growth during the historic period can be credited to a rise in cardiovascular diseases, an aging population at cardiovascular risk, health awareness campaigns and screenings, the inclusion of biomarkers in clinical practice, along with stringent regulations and guidelines.

In the coming years, a swift expansion is anticipated in the cardiac marker market, projected to reach a size of $20.35 billion in 2029, escalating at a compound annual growth rate (CAGR) of 13.0%. Such growth in the prediction interval is linked to the increasing influence of diseases related to lifestyle, advancements in remote monitoring and telemedicine, precision diagnostics, point-of-care testing (poct) adoption, and healthcare partnerships. Leading trends for the projected period include the discovery and validation of biomarkers, personal medicine strategies, advancements in assay platform technology, the integration of high-sensitivity troponin tests, and an upsurge in the prevalence of cardiovascular disease.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10053

What New Market Trends Are Reshaping theCardiac Marker Market and Its Opportunities?

The cardiac marker market is witnessing a rise in product innovation, with leading market entities emphasizing innovative solutions to consolidate their market standing. An example of this is Singaporean biotech company, MiRxes, which as of September 2022, ratified a diagnostic test based on microRNA for the initial detection and diagnosis of diseases. The inclusion of this test in their commercial offerings will enrich MiRxes’ existing gamut of blood tests for cancer, thereby providing an extensive array of early detection methods. This will help in reducing the growing clinical and socioeconomic implications of lethal diseases, such as cancer and cardio-pulmonary ailments.

Who Are the Leading Market Players Fueling Growth in the Cardiac Marker Market Trend?

Major companies operating in the cardiac marker market include Abbott Laboratories Inc., Siemens AG, Danaher Corporation, BioMérieux SA, F. Hoffmann-La Roche AG, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Guangzhou Wondifo Biotech Co. Ltd., Creative Diagnostics, PerkinElmer Inc., Tosoh Corporation, Quidel Corporation, Randox Laboratories Ltd., Getinge Group, LSI Medience Corporation, Ortho Clinical Diagnostics, DiaSorin, 3M Company, Atom Medical Corporation, Bionet America Inc., Bistos Inc., CareFusion Corporation, Clinical Innovations LLC, Abcam plc, General Electric Company

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/cardiac-marker-global-market-report

How is the Global Cardiac Marker Market Segemented?

The cardiac marker market covered in this report is segmented –

1) By Biomarker: Troponin, Creatine Kinase-MB (CK-MB), B-type Natriuretic Peptide (BNP), Myoglobin, Other Biomarkers

2) By Product: Reagent, Instrument, Chemiluminescence, Immunofluorescence, Immunochromatography, ELISA

3) By Indication: Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Other Indications

4) By End User: Laboratory Testing Facilities, Hospital Labs, Reference Labs, Contract Testing Labs, Point-Of-Care Testing Facilities, Academic Institutions

Subsegments:

1) By Troponin: Troponin I, Troponin T, Troponin Diagnostic Kits

2) By Creatine Kinase-MB (CK-MB): CK-MB Test Kits, CK-MB Diagnostic Panels

3) By B-Type Natriuretic Peptide (BNP): BNP Test Kits, NT-ProBNP Test Kits, BNP Diagnostic Panels

4) By Myoglobin: Myoglobin Test Kits, Myoglobin Diagnostic Panels

5) By Other Biomarkers: Ischemia Modified Albumin (IMA), Heart Fatty Acid Binding Protein (HFABP), C-Reactive Protein (CRP)

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=10053&type=smp

Which Geographics are Influencing the Growth of the Cardiac Marker Market?

North America was the largest region in the cardiac marker market in 2024. The regions covered in the cardiac marker market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Reports Similar to the Gobal Cardiac Marker Maret 2025, By The Business Research Company:

Cardiovascular Monitoring And Diagnostic Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cardiovascular-monitoring-and-diagnostic-devices-and-equipment-global-market-report

Pacemakers Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pacemakers-global-market-report

Cardiovascular Surgery Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cardiovascular-surgery-devices-and-equipment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the cardiac marker market grown in recent years?

The size of the cardiac marker market has seen a significant increase recently. It is projected to expand from $11.26 billion in 2024 to $12.47 billion in 2025, reflecting a compound annual growth rate (CAGR) of 10.8%. The growth observed in the past period can be associated with factors such as the rise in cardiovascular diseases, an aging demographic with cardiovascular risks, the impact of health awareness programs and screenings, the introduction of biomarkers in clinical practices, as well as strict regulatory standards and rules.

How is the cardiac marker market size expected to evolve during the forecast period?

In the coming years, the cardiac marker market is projected to experience explosive growth. It is forecasted to reach a valuation of “$20.35 billion by 2029, growing at a compound annual growth rate (CAGR) of 13.0%. The various contributing factors to this predicted growth can be credited to the increasing prevalence of lifestyle-related illnesses, the emergence of remote monitoring and telemedicine, strategies for personalized healthcare and precision diagnostics, the uptake of point-of-care testing (poct), and cooperations and collaborations within the healthcare sector. Key trends to watch during this forecast period will be the discovery and validation of biomarkers, personalized medical methodologies, technological enhancements in assay platforms, inclusion of high-sensitivity troponin tests, and a rise in the frequency of cardiovascular diseases.

Get your cardiac marker market report here!

https://www.thebusinessresearchcompany.com/report/cardiac-marker-global-market-report

Which key drivers are propelling the cardiac marker market’s growth?

The cardiac marker market is anticipated to expand as a result of the increasing rate of heart diseases. Cardiac diseases, which can disrupt the normal operation or structure of the heart resulting in various health issues, are making the need for cardiac markers more and more crucial. These markers help in the detection and monitoring of a variety of heart conditions like heart attacks, angina, heart failure, and other cardiovascular diseases. As such, there’s a growing demand for these diagnostic tests. For example, the British Heart Foundation, a cardiovascular research charity based in the UK, reported that from the beginning of the pandemic until August 2022, England saw a surge in coronary heart disease deaths by 30,000. By the end of August 2022, a whopping 346,000 individuals were on the cardiac waiting list. Consequently, the escalating incidence of heart diseases is expected to drive the growth of the cardiac marker market.

What are the market segments in the cardiac marker industry?

The cardiac marker market covered in this report is segmented –

1) By Biomarker: Troponin, Creatine Kinase-MB (CK-MB), B-type Natriuretic Peptide (BNP), Myoglobin, Other Biomarkers

2) By Product: Reagent, Instrument, Chemiluminescence, Immunofluorescence, Immunochromatography, ELISA

3) By Indication: Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Other Indications

4) By End User: Laboratory Testing Facilities, Hospital Labs, Reference Labs, Contract Testing Labs, Point-Of-Care Testing Facilities, Academic Institutions

Subsegments:

1) By Troponin: Troponin I, Troponin T, Troponin Diagnostic Kits

2) By Creatine Kinase-MB (CK-MB): CK-MB Test Kits, CK-MB Diagnostic Panels

3) By B-Type Natriuretic Peptide (BNP): BNP Test Kits, NT-ProBNP Test Kits, BNP Diagnostic Panels

4) By Myoglobin: Myoglobin Test Kits, Myoglobin Diagnostic Panels

5) By Other Biomarkers: Ischemia Modified Albumin (IMA), Heart Fatty Acid Binding Protein (HFABP), C-Reactive Protein (CRP)

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10053&type=smp

Which leading companies are shaping the growth of the cardiac marker market?

Major companies operating in the cardiac marker market include Abbott Laboratories Inc., Siemens AG, Danaher Corporation, BioMérieux SA, F. Hoffmann-La Roche AG, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Guangzhou Wondifo Biotech Co. Ltd., Creative Diagnostics, PerkinElmer Inc., Tosoh Corporation, Quidel Corporation, Randox Laboratories Ltd., Getinge Group, LSI Medience Corporation, Ortho Clinical Diagnostics, DiaSorin, 3M Company, Atom Medical Corporation, Bionet America Inc., Bistos Inc., CareFusion Corporation, Clinical Innovations LLC, Abcam plc, General Electric Company

What key trends are currently impacting the cardiac marker market’s development?

The cardiac marker market is observing a surge in product innovation, a trend that is becoming increasingly popular. Key players in the market are focusing on introducing novel solutions to reinforce their market status. For instance, MiRxes, a biotechnology company based in Singapore, confirmed a diagnostic test based on microRNA in September 2022 for the early detection and diagnosis of diseases. Once it is made commercial, the test will supplement MiRxes’ suite of blood cancer tests, providing a comprehensive choice of early detection methods meant to alleviate the escalating clinical and socioeconomic impact of serious diseases, such as cancer and heart-lung disorders.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10053

Which geographic areas are influencing the growth of the cardiac marker market?

North America was the largest region in the cardiac marker market in 2024. The regions covered in the cardiac marker market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Cardiovascular Monitoring And Diagnostic Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cardiovascular-monitoring-and-diagnostic-devices-and-equipment-global-market-report

Pacemakers Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pacemakers-global-market-report

Cardiovascular Surgery Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cardiovascular-surgery-devices-and-equipment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Projected Compound Annual Growth Rate (CAGR) of the Cardiac Marker Market from 2025 to 2034, and What Factors Influence It?

In recent times, the cardiac marker market has expanded swiftly. It is projected to escalate from $11.26 billion in 2024 to $12.47 billion in 2025, boasting a compound annual growth rate (CAGR) of 10.8%. Factors such as the rising occurrence of cardiovascular conditions, population aging and cardiovascular risk, the introduction of health awareness campaigns and screenings, the incorporation of biomarkers into clinical practice, and strict regulatory norms and guidelines have all contributed to this historical growth trend.

In the forthcoming years, the cardiac marker market is set to experience substantial growth with an expected value of $20.35 billion by 2029, witnessing a compound annual growth rate (CAGR) of 13.0%. The expansion in the forecast period is attributed to factors such as the increasing incidence of lifestyle-related illnesses, the adoption of remote monitoring and telemedicine, precision diagnostics and personalized medicine, the uptake of point-of-care testing (POCT), and partnerships and collaborations in the healthcare sector. Key trends predicted for the forecast period encompass discovery and validation of biomarkers, customized medical treatment strategies, advancements in diagnostic platform technology, integration of highly sensitive troponin tests, and an increase in the rate of cardiovascular diseases.

What Industry-Specific Factors Are Fueling the Growth of the cardiac marker Market?

The growing frequency of heart-related conditions is likely to boost the expansion of the cardiac marker market in the future. Cardiac disorders encompass a variety of conditions that influence the heart’s structure or function, leading to an array of health problems. Cardiac markers play a pivotal role in the detection and monitoring of multiple heart-related conditions such as heart attacks, angina, heart failure, and other cardiovascular diseases. Consequently, there has been an uptick in the demand for diagnostic tests or cardiac markers. For example, the British Heart Foundation, a cardiovascular research charity based in the UK, reported that England experienced 30,000 additional deaths from coronary heart disease from the onset of the pandemic until August 2022. An unprecedented 346,000 individuals were on a cardiac waiting list by the end of August 2022. For these reasons, the growing incidence of heart diseases is predicted to drive the growth of the cardiac marker market.

Request Your Free Cardiac Marker Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=10053&type=smp

Who Are the Leading Players Fueling Growth in the Cardiac Marker Market?

Major companies operating in the cardiac marker market include:

• Abbott Laboratories Inc._x000D_

• Siemens AG_x000D_

• Danaher Corporation_x000D_

• BioMérieux SA_x000D_

• F. Hoffmann-La Roche AG_x000D_

What Are the Emerging Trends Shaping the Future of the Cardiac Marker Market?

A prominent trend emerging in the cardiac marker market is the emphasis on product innovation. Leading market players are concentrating on pioneering solutions to cement their standing in the market. For example, in September 2022, a biotechnology company from Singapore, MiRxes, confirmed a diagnostic test based on microRNA for early identification and diagnosis of diseases. Upon commercialization, this test will augment MiRxes’ assortment of blood tests for cancer, delivering a comprehensive set of early detection alternatives that aim to mitigate the growing clinical and socioeconomic impact of deadly diseases such as cancer and cardio-pulmonary disorders.

Pre-order Your Report for Quick and Easy Delivery!

https://www.thebusinessresearchcompany.com/report/cardiac-marker-global-market-report

Which Primary Segments of the Cardiac Marker Market Are Driving Growth and Industry Transformations?

The cardiac marker market covered in this report is segmented –

1) By Biomarker: Troponin, Creatine Kinase-MB (CK-MB), B-type Natriuretic Peptide (BNP), Myoglobin, Other Biomarkers

2) By Product: Reagent, Instrument, Chemiluminescence, Immunofluorescence, Immunochromatography, ELISA

3) By Indication: Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Other Indications

4) By End User: Laboratory Testing Facilities, Hospital Labs, Reference Labs, Contract Testing Labs, Point-Of-Care Testing Facilities, Academic Institutions

Subsegments:

1) By Troponin: Troponin I, Troponin T, Troponin Diagnostic Kits

2) By Creatine Kinase-MB (CK-MB): CK-MB Test Kits, CK-MB Diagnostic Panels

3) By B-Type Natriuretic Peptide (BNP): BNP Test Kits, NT-ProBNP Test Kits, BNP Diagnostic Panels

4) By Myoglobin: Myoglobin Test Kits, Myoglobin Diagnostic Panels

5) By Other Biomarkers: Ischemia Modified Albumin (IMA), Heart Fatty Acid Binding Protein (HFABP), C-Reactive Protein (CRP)

Which Regions Are Driving Growth in the Cardiac Marker Market?

North America was the largest region in the cardiac marker market in 2024. The regions covered in the cardiac marker market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Defines the Scope of the Cardiac Marker Market?

Cardiac markers are biomolecules that are released into the bloodstream when there is damage or stress to the heart muscle. It is used to diagnose and monitor a variety of cardiac diseases, including heart attacks, angina, and heart failure.

Browse Through More Similar Reports By The Business Research Company:

Cardiovascular Monitoring And Diagnostic Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cardiovascular-monitoring-and-diagnostic-devices-and-equipment-global-market-report

Pacemakers Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pacemakers-global-market-report

Cardiovascular Surgery Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cardiovascular-surgery-devices-and-equipment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: